Bright Minds Biosciences Inc.

DRUG | NASDAQ

$61.19

+$1.73 (+2.91%)

Sep 22, 2026, 1:05 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Sep 29, 2025	FY 2024 Sep 29, 2024	FY 2023 Sep 29, 2023	FY 2022 Sep 29, 2022	FY 2021 Sep 29, 2021	FY 2020 Sep 29, 2020
PE Ratio	-47.44	-2.43	-1.10	-1.38	-9.55	-94.61
PEG Ratio	-0.27	0.04	0.02	-0.05	-0.01	-0.18
PS Ratio	n/a	n/a	n/a	n/a	n/a	n/a
PB Ratio	7.08	1.23	1.22	1.99	4.19	63.14
P/FCF Ratio	-66.82	-3.69	-1.15	-1.55	-11.10	-159.66
P/OCF Ratio	-66.82	-3.69	-1.15	-1.55	-11.10	-159.66
OCF/S Ratio	n/a	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0	0.02	0.01	0.01	n/a	n/a
Quick Ratio	36.10	11.32	24.26	8.11	31.38	5.82
Current Ratio	36.10	11.32	24.26	8.11	31.38	5.82
Asset Turnover	n/a	n/a	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a	n/a	n/a	n/a
Return on Equity	-14.91%	-50.61%	-111.73%	-141.95%	-44.59%	-65.87%
Return on Assets	-14.49%	-45.90%	-107.17%	-123.81%	-43.17%	-54.57%
Return on Invested Capital	-16.96%	-49.91%	-110.71%	-140.18%	-44.45%	-65.12%
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a	n/a	n/a